Ozone Therapy in Refractory Ischemic Heart Disease.

NCT03660657 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
TERMINATED
Status
1
Enrollment
OTHER
Sponsor class

Stopped Very low recruitment. During COVID-19 pandemic these are patients of high risk.

Conditions

Interventions

Sponsor

Bernardino Clavo, MD, PhD

Collaborators